GlassScriptPhysician profile
Abhinav Singh
NPI 1194841254
$869.76
in general payments reported to CMS, 2019-2025
12 companies · $92.46 in 2025
The $92.46 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.92 · 2020: $180 · 2021: $77.10 · 2022: $90.15 · 2023: $190 · 2024: $177 · 2025: $92.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $423.52 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $195.71 | 2023-2025 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $55.94 | 2024-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $46.55 | 2022-2023 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $30.86 | 2019 | |
| Axsome Therapeutics, INC. | $25.08 | 2023 | Sunosi |
| Abbvie INC. | $23.64 | 2024 | |
| Inspire Medical Systems, INC. | $17.79 | 2023 | Inspire |
| Vanda Pharmaceuticals INC. | $14.26 | 2024 | Fanapt |
| Idorsia Pharmaceuticals US INC | $13.10 | 2023 | Quviviq |
| Resmed Corp | $12.45 | 2020 | |
| Glaxosmithkline, LLC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.